Skip to main content
Log in

Pharmacokinetics of ketamine and two metabolites in the dog

  • Published:
Journal of Pharmacokinetics and Biopharmaceutics Aims and scope Submit manuscript

Abstract

The plasma concentrations of ketamine, N-demethylketamine (I), and the cyclohexene metabolite (II) formed by oxidation of I were determined at various times after rapid i.v. administration of 15 mg of ketamine HCl/kg of body weight to dogs. A pharmacokinetic model that included two compartments for ketamine and one compartment for each metabolite was developed. Ketamine distributed rapidly with (t 1/2 α averaging 1.95 min. The apparent volumes of the central and peripheral compartments for ketamine averaged 542 and 1940 ml/kg of body weight, respectively, and the (t 1/2 )β averaged 61 min. The model indicated that 62% of ketamine was transformed to I and that 11% of I was converted to II. The apparent volumes of distribution of I and II averaged 61% and 59% of body weight, respectively. The total body clearances (plasma) of ketamine, I, and II averaged 32.2, 89.4, and 8.54 ml/min/kg, respectively. Plasma protein binding was determined by equilibrium dialysis; it averaged 53.5% for ketamine (concentration range 0.34– 19.5 μg/ml), 60.3% for I (0.05– 19.6 μg/ml), and 70.1% for II (0.09– 0.58 μg/ml). A minimum anesthetic concentration of 3 μg ketamine HCl/ml plasma was used with the model to predict that the duration of ketamine anesthesia after an i.m. dose would not be significantly affected if the absorption t1/2 varied from 0.48 to 31 min. The model also predicted that accumulation of I and II would not interfere with ketamine anesthesia that was prolonged by repeated doses, each dose administered i.v. on termination of anesthesia from the previous dose.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. R. W. Virtue, J. M. Alanis, M. Mori, R. T. Lafargue, J. H. K. Vogel, and D. R. Metcalf. An anesthetic agent: 2-Orthochlorophenyl, 2-methylamino cyclohexanone HC1. (CI-581).Anesthesiology. 28:823–833 (1967).

    Article  CAS  PubMed  Google Scholar 

  2. M. L. Cohen, S.-L. Chan, W. L. Way, and A. J. Trevor. Distribution in the brain and metabolism of ketamine in the rat after intravenous administration.Anesthesiology 39:370–376 (1973).

    Article  CAS  PubMed  Google Scholar 

  3. J. Wieber, R. Gugler, J. H. Hengstmann, and H. J. Dengler. Pharmacokinetics of ketamine in man.Anaesthetist 24:260–263 (1975).

    CAS  Google Scholar 

  4. M. P. Marietta, W. L. Way, N. Castagnoli, Jr., and A. J. Trevor. On the pharmacology of the ketamine enantiomorphs in the rat.J. Pharmacol. Exp. Ther. 202:157–165 (1977).

    CAS  PubMed  Google Scholar 

  5. S. Ryder, W. L. Way, and A. J. Trevor. Comparative pharmacology of the optical isomers of ketamine in mice.eur. J. Pharmacol. 49:15–23 (1978).

    Article  CAS  PubMed  Google Scholar 

  6. T. Chang and A. J. Glazko. A gas chromatographic assay for ketamine in human plasma.Anesthesiology 36:401–404 (1972).

    Article  CAS  PubMed  Google Scholar 

  7. J. D. Baggot and J. W. Blake. Disposition kinetics of ketamine in the domestic cat.Arch. Int. Pharmacodyn. Ther. 220:115–124 (1976).

    CAS  PubMed  Google Scholar 

  8. J. S. Kaka, P. A. Klavano, and W. L. Hayton. Pharmacokinetics of ketamine in the horse.Am. J. Vet. Res. 40:978–981 (1979).

    CAS  PubMed  Google Scholar 

  9. M. P. Marietta, P. F. White, C. R. Pudwill, W. L. Way, and A. J. Trevor. Biodisposition of ketamine in the rat: Self-induction of metabolism.J. Pharmacol. Exp. Ther. 196:536–544 (1976).

    CAS  PubMed  Google Scholar 

  10. P. F. White, M. P. Marietta, C. R. Pudwill, W. L. Way, and A. J. Trevor. Effects of halothane anesthesia on the biodisposition of ketamine in rats.J. Pharmacol. Exp. Ther. 196:545–555 (1976).

    CAS  PubMed  Google Scholar 

  11. L. Z. Benet. General treatment of linear mammillary models with elimination from any compartment as used in pharmacokinetics.J. Pharm. Sci. 61:536–541 (1972).

    Article  CAS  PubMed  Google Scholar 

  12. C. M. Metzler, G. L. Elfring, and A. J. McEwen. A package of computer programs for pharmacokinetic modeling.Biometrics 30:562–563 (1974).

    Article  Google Scholar 

  13. S. Feldman. Drug distribution.Med. Clin. North Am. 58:917–926 (1974).

    CAS  PubMed  Google Scholar 

  14. H. D. Green. Circulatory system: physical principles. In O. Glasser (ed.),Medical Physics, Vol. 2, Year Book Publishers, Chicago, 1950, p. 244.

    Google Scholar 

  15. H. R. Adams, J. L. Parker, and B. P. Mathew. The influence of ketamine on inotropic and chronotropic responsiveness of heart muscle.J. Pharmacol. Exp. Ther. 201:171–183 (1977).

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kaka, J.S., Hayton, W.L. Pharmacokinetics of ketamine and two metabolites in the dog. Journal of Pharmacokinetics and Biopharmaceutics 8, 193–202 (1980). https://doi.org/10.1007/BF01065193

Download citation

  • Received:

  • Revised:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01065193

Key words

Navigation